WOMEN’S HEALTH
More Products
Provide Point-of-care testing kits and auxiliary diagnostic products for health monitoring of women and their partners
Molecular Diagnosis
MammaTyper®
MammaTyper® is a standardised multiplex real-time qPCR assay co-developed by Shuwen and BioNTech (Germany). The assay kit allows pathologists to amplify, detect and quantify the mRNA expression status of 6 genes to most appropriately and accurately subtype breast cancer in the patients (as recommended by St Gallen, 2013 and subsequent updates).
EndoPredict®
EndoPreidct® is the second generation of multi-gene for prognostic prediction of breast cancer.
MTHFR Genetic Test Kit
Explore the individual metabolic capacity of folic acid to establish personalized supplement scheme, which contribute to birth defects reduction and disease prevention.
Nucleic Acid Extraction & Purification Kit
Cerca nucleic acid extraction and purification kit releases nucleic acid in tissue sections through lysis solution, binding solution system makes efficient combination of nucleic acid and magnetic bead, and obtains high purity, stable quality nucleic acid through the unique washing system.
RDS®
By using PCR method to detect the mRNA expression levels of genes related to DNA repair pathway, it can assist in determining the sensitivity of tumor DNA damage treatment plans, including platinum based chemotherapy drugs, and help clinical selection of appropriate treatment plans.
Cerca® NAP-T8
Cerca NAP-T8 is an automatic nucleic acid extractor developed by Shuwen Biotech, and used for nucleic acid extraction, enrichment, and purification from FFPE samples using magnetic bead mediated selective adsorption mechanism. The extracted DNA or RNA can be used for molecular pathological detection such as qPCR, Next-generation sequencing (NGS)
Immunodiagnosis
FOXCARD®
An IHC kit for subtyping triple negative breast cancer (TNBC) and guiding improved TNBC therapy. It is developed based on Fudan Subtyping proposed by Professor Zhiming Shao of Fudan University Cancer Hospital. Shuwen has acquired patents on the technology from the hospital and collaborates with Prof. Shao for its commercialization.
PD-L1 Kit for IHC
An immunohistochemistry kit registered in China that has been extensively validated in various tumor types and used in testing tens of thousands of clinical trial samples for our pharmaceutical company clients.
Poinr-of-Care Test
CapCord®
Through quantitative detection of misfolded proteins by spectrophotometer in pregnant women’s urine, to improve the early detection rate of preeclampsia and predict the incidence of preeclampsia in advance.
CercaTest® RED
CercaTest® RED is a new version of a well documented technique to detect misfolded proteins in the urine of pregnant mothers. In multiple studies this is shown to be an indicator of poor pregnancy outcomes.
